Protactinium

coagulation factor II, thrombin ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 11522018 Complementary roles for fibrin(ogen), thrombospondin and vWF in mediating shear-dependent aggregation of platelets stimulated at threshold thrombin concentrations. 2001 Aug 1
2 9795233 Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets. 1998 Nov 2 1
3 10603527 NPC 15669, an Antiinflammatory Leucine Derivative, Reduces In Vitro Platelet Aggregability in Both Swine and Human Plasma. 1995 1
4 21043698 Nitric Oxide (NO)-Platelet Interactions: Inhibition is Independent of the Prostanoid and ADP Pathways. 1995 1
5 2113968 Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells. 1990 Jun 2
6 2546796 Potentiation by adrenaline of thrombin-induced elevation of pHi is not essential for synergistic activation of human platelets. 1989 Jul 3 1
7 2845924 Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism. 1988 Jul 15 1
8 3496679 Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. 1987 Apr 7 2
9 3085533 A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators. 1986 Mar 1
10 3730298 Liberation of surface and internal platelet-associated IgG (PA-IgG) during platelet activation. 1986 Aug 2
11 6189238 Pharmacological observations of plasminogen activator release caused by vasoactive agents in isolated perfused pig ears. 1983 Jan 15 1
12 14349763 Changes in plasma proconvertin and prothrombin during PAS therapy. 1954 1
13 13055031 [Prothrombin index during PAS therapy]. 1953 Feb 20 1